Chart of the Week: Hepatitis C – Gilead Wins

Jun 28, 2016 | News

In honor of Gilead’s newly approved, and cheaper, hepatitis C drug we decided to show the biomarker, trial and company landscape for hepatitis C. You can read more about Gilead’s new drug here, here and here. Purple: Company Red: Trials Blue: Biomarkers...

Chart of the Week: Biopharma Players in Alzheimers

Jun 8, 2016 | News

We’ve published a few “graphs” illustrating topics interesting to us.  Last month published a graph showing Celgene’s biomarker and trial activities.  More recently we published a biomarker and trial landscape graph for Alzheimer’s...

Chart of the Week: Update: Unique Biomarkers in Pharma

May 24, 2016 | News

On January 29th, we posted a CotW outlining the top 10 pharma companies by number of unique biomarkers those companies are using in trials.  We thought it was about time to update that chart and expand it to the top 25 pharma companies. Interesting facts to note:...

Chart of the Week: Alzheimer’s Biomarker and Trial Landscape

May 17, 2016 | News

This week’s CotW includes the landscape of biomarkers and clinical trials for Alzheimer’s disease.  There is significant clustering around two biomarkers, but many interesting emerging biomarkers in clinical trials. Gray: Disease Blue: Biomarkers...